Aurobindo acquires Apotex's operations in 5 European countries

The company had inked a binding agreement on July 14, 2018, to acquire five of Apotex' European businesses.

View in App
Representative Image
Aurobindo Pharma Monday said it has completed the EUR 74-million deal to acquire Apotex's commercial operations and certain supporting infrastructure in five European countries.

The company had inked a binding agreement on July 14, 2018, to acquire five of Apotex' European businesses, including infrastructure, personnel, products, certain established trademarks, marketing authorisations and dossier licence rights in Poland, the Czech Republic, the Netherlands, Spain and Belgium, Aurobindo Pharma said in a regulatory filing.

This announcement does not constitute a recommendation to shareholders or potential investors, it added.


Aurobindo Pharma shares were trading 0.94 per cent down at Rs 753.50 apiece on the BSE.
Start a SIP with as low as ₹500 with ET Money App!
Download The
Economic Times Business News App
for the Latest News in Business, Market & More.
READ MORE
View in App
downloadApp
ADVERTISEMENT

READ MORE:

LOGIN & CLAIM

50 TIMESPOINTS

Related Companies

ET Business Listings
Generate Enquiries for your Business by Listing on Economictimes.com

More from our Partners

Loading next story
Text Size:AAA

ET Sections

View Full Site »
Download App

More from our network

Success
This article has been saved

*